EDITEK INC
SC 13D/A, 1997-01-13
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: PENWEST LTD, 10-Q, 1997-01-13
Next: ZWEIG DIMENNA PARTNERS L P, SC 13D, 1997-01-13





                           SECURITIES AND EXCHANGE COMMISSION
                                   WASHINGTON, DC 20549


                                     SCHEDULE 13D

                        Under the Securities Exchange Act of 1934
                                   (Amendment No.   3  ) (1)

                                   EDITEK, INC.
- -------------------------------------------------------------------------------
                                  (Name of issuer)


                                   COMMON STOCK
- -------------------------------------------------------------------------------
                            (Title of class of securities)

                                    281068106
- -------------------------------------------------------------------------------
                                  (CUSIP number)

     DAVID SELENGUT, c/o Singer, Bienenstock, Zamansky, Ogele & Selengut, LLP.
               40 Exchange Place, New York, NY 10005 (212) 809-8550
- -------------------------------------------------------------------------------
                  (Name, address and telephone number of person
                authorized to receive notices and communications)


                                 December 24, 1996
- -------------------------------------------------------------------------------
                   (Date of event which requires filing of this statement)

         If the filing person has  previously  filed a statement on Schedule 13G
to report the  acquisition  which is the subject of this  Schedule  13D,  and is
filing this schedule  because of Rule 13d-1 (b) (3) or (4),  check the following
box o.

         Check the following box if a fee is being paid with the statement X. (A
fee is not required only if the reporting person:  (1) has a previous  statement
on file reporting beneficial ownership of more than five percent of the class of
securities  described  in Item 1;  and (2) has  filed  no  amendment  subsequent
thereto reporting  beneficial  ownership of five percent or less of such class.)
(See Rule 13d-7.)

     Note. Six copies of this statement,  including all exhibits, should be file
with the Commission.  See Rule 13d-1 (a) for other parties to whom copies are to
be sent.

      

                               (Page 1 of 3 Pages)
- --------------
   (1) The  remainder  of this cover page shall be filled out for a reporting
person's  initial  filing on this  form with  respect  to the  subject  class of
securities,  and for any subsequent amendment containing information which would
alter disclosures provided in a prior cover page.

     The  information  required on the remainder of this cover page shall be
deemed to be "filed"  for the purpose of Section 18 of the  Securities  Exchange
Act of 1934 or otherwise  subject to the  liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the Notes)








<PAGE>

CUSIP No. 281068106            13D/A               Page 2 of 3 Pages

          NAME OF REPORTING PERSONS
          S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS 

          Morgan Capital LLC
_______________________________________________________________________________

2         CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*           (a) o
                                                                      (b) o

_______________________________________________________________________________

3         SEC USE ONLY

_______________________________________________________________________________

4         SOURCE OF FUNDS*  

          PF
_______________________________________________________________________________

5         CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
          TO ITEM 2(d) or 2 (e)
                                                                               
_______________________________________________________________________________

6         CITIZENSHIP OR PLACE OF ORGANIZATION

          New York
_______________________________________________________________________________

                    7    SOLE VOTING POWER
      NUMBER OF
        SHARES              3,308,727
_______________________________________________________________________________

     BENEFICIALLY   8    SHARED VOTING POWER
       OWNED BY
                              -0-
_______________________________________________________________________________
         EACH       9    SOLE DISPOSITIVE POWER
      REPORTING
                             3,308,727
_______________________________________________________________________________

     PERSON WITH   10    SHARED DISPOSITIVE POWER

                              -0-
_______________________________________________________________________________


   11     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

                              3,308,727
_______________________________________________________________________________

   12     CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
          CERTAIN SHARES*         
                                                                 

_______________________________________________________________________________

   13     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

                               13.11%
_______________________________________________________________________________

   14     TYPE OF REPORTING PERSON*

          00 Limited Liability Company
_______________________________________________________________________________

                 *SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
                                                           Page 3 of 3 Pages

    
Morgan Capital LLC ("Morgan" or the "Reporting Entity") hereby amends the 
Statement on Schedule 13D as follows:

Item 5 is hereby amended as follows:

     Interest in Securities of Issuer
     Number of Shares - 3,308,727
     Percentage of Shares - 13.11%
     Reporting Entity sold 508,100 shares in the open market in the past 
     seventeen days at prices between 9/16 and 5/8.



 

                                 SIGNATURE


         After reasonable  inquiry and to the best of my knowledge and belief, I
certify that the information  set forth in this statement is true,  complete and
correct.

 

     January 10, 1997
                                             Morgan Capital LLC.


                                            /s/ David Bistricer
                                        BY:_____________________________

                                            David Bistricer, Officer
                                               
                                                         







© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission